Clinical Significance of FBXO17 Gene Expression in High-Grade Glioma

BMC Cancer - United Kingdom
doi 10.1186/s12885-018-4680-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

International Differences in Treatment and Clinical Outcomes for High Grade Glioma

PLoS ONE
Multidisciplinary
2015English

Circulating Biomarkers for High-Grade Glioma

Biomarkers in Medicine
BiochemistryDrug DiscoveryClinical Biochemistry
2019English

Clinical Significance Ofin Vivocytarabine-Induced Gene Expression Signature in AML

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2015English

Prognostic Significance of Age Related Genes in Patients With Lower Grade Glioma

Journal of Cancer
Oncology
2020English

Expression Level of CDC2 Gene in Osteosarcoma and Its Clinical Significance

Oncology Letters
Cancer ResearchOncology
2018English

Clinical Management of Seizures in Patients With Low-Grade Glioma

Seminars in Radiation Oncology
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2015English

Profile of Nimotuzumab in the Treatment of High-Grade Glioma

OncoTargets and Therapy
OncologyPharmacology
2015English

Treatment Outcome of High-Grade Spinal Cord Glioma

Spinal Surgery
2013English

Phospholipase C Beta 1: A Candidate Signature Gene for Proneural Subtype High-Grade Glioma

Molecular Neurobiology
NeuroscienceNeurologyCellularMolecular Neuroscience
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy